 <h1>Idelvion Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>coagulation factor ix</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about coagulation factor ix. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Idelvion.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to coagulation factor ix: intravenous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, coagulation factor ix (the active ingredient contained in Idelvion) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking coagulation factor ix:</p><p>
<i>More common</i>
</p><ul>
<li>Cough</li>
<li>fever</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Back or side pain</li>
<li>blurred vision</li>
<li>chest tightness</li>
<li>chills</li>
<li>confusion</li>
<li>difficult or labored breathing</li>
<li>fast heartbeat</li>
<li>hives</li>
<li>itching, pain, redness, swelling, tenderness, blue discoloration, or warmth of the skin at the injection site</li>
<li>nausea</li>
<li>swelling of the foot or leg</li>
<li>vomiting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Anxiety</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>chest pain</li>
<li>difficulty with swallowing</li>
<li>dizziness, fainting, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>itching, skin rash</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals</li>
<li>pains in the chest, groin, or legs, especially calves of the legs</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>restlessness</li>
<li>severe headaches of sudden onset</li>
<li>sudden loss of coordination</li>
<li>sudden onset of slurred speech</li>
<li>sudden vision changes</li>
<li>sweating</li>
<li>tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over affected area</li>
<li>unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of coagulation factor ix may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Headache</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Change in or loss of taste</li>
<li>drowsiness</li>
<li>feeling of warmth</li>
<li>pain in the arms or legs</li>
<li>redness of the face, neck, arms, and occasionally, the upper chest</li>
<li>shaking</li>
</ul><p>
<!-- end intravenous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to coagulation factor ix: intravenous kit, intravenous powder for injection</i></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity (including bronchospastic reactions and/or hypotension, anaphylaxis, development of high-titer inhibitors necessitating alternative treatment)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Factor IX inhibition<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash pruritic, hives<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site discomfort, injection site pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dysgeusia, lethargy, dizziness, shaking, drowsiness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dry cough, hypoxia, chest tightness, dyspnea<sup>[Ref]</sup></p><h3>Renal</h3><p>The renal infarct occurred in a hepatitis C antibody positive patients 12 days after treatment of a bleeding episode; the relation of the infarct to the prior administration of this drug is uncertain.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Renal infarct<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza, cellulitis at injection site, phlebitis at injection site<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Apathy, depression<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Hemophilia (lack of efficacy), asthenia, fever, chills<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Flushing<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. BeneFIX (coagulation factor IX)." Wyeth Laboratories, Philadelphia, PA. </p><p id="ref_2">2. "Product Information. Ixinity (coagulation factor IX)." Cangene bioPharma, Inc., Baltimore, MD. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Idelvion (coagulation factor ix)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous coagulation modifiers</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Idelvion Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>BeneFix, Alprolix, Rixubis, Ixinity, ... +3 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Hemophilia B</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to coagulation factor ix: intravenous kit, intravenous powder for injection</i></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity (including bronchospastic reactions and/or hypotension, anaphylaxis, development of high-titer inhibitors necessitating alternative treatment)<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Factor IX inhibition<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea, vomiting<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash pruritic, hives<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site discomfort, injection site pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dysgeusia, lethargy, dizziness, shaking, drowsiness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dry cough, hypoxia, chest tightness, dyspnea<sup>[Ref]</sup></p><h3>Renal</h3><p>The renal infarct occurred in a hepatitis C antibody positive patients 12 days after treatment of a bleeding episode; the relation of the infarct to the prior administration of this drug is uncertain.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Renal infarct<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza, cellulitis at injection site, phlebitis at injection site<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Apathy, depression<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Hemophilia (lack of efficacy), asthenia, fever, chills<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Flushing<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. BeneFIX (coagulation factor IX)." Wyeth Laboratories, Philadelphia, PA. </p><p id="ref_2">2. "Product Information. Ixinity (coagulation factor IX)." Cangene bioPharma, Inc., Baltimore, MD. </p><h2>More about Idelvion (coagulation factor ix)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous coagulation modifiers</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Idelvion Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hemophilia B</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>